Venn Life Sciences (LON:VENN) Stock Crosses Above 50 Day Moving Average – Should You Sell?

Venn Life Sciences Holdings PLC (LON:VENN) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares changing hands.

Venn Life Sciences Stock Performance

The company has a debt-to-equity ratio of 35.83, a current ratio of 2.30 and a quick ratio of 1.48. The stock has a market capitalization of £4.89 million and a P/E ratio of -2.14. The company has a 50 day simple moving average of GBX 6.85 and a 200-day simple moving average of GBX 6.85.

Venn Life Sciences Company Profile

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.